Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterizing m6A modification factors and their interactions in colorectal cancer: implications for tumor subtypes and clinical outcomes. | Discov Oncol | 2024 | 39292326 | PubTator, text mining | PubMed |
| Molecular mechanism of ALKBH5-mediated m6A demethylation regulating lipopolysaccharide-induced epithelial-mesenchymal transition in sepsis-induced acute kidney injury. | Kaohsiung J Med Sci | 2024 | 39287046 | PubTator, text mining | PubMed |
| Ouabain-mediated downregulation of ALKBH5 and IGF2BP2 inhibits the malignant progression of DLBCL. | Front Pharmacol | 2024 | 39281280 | PubTator, text mining | PubMed |
| Increased m6A RNA methylation and METTL3 expression may contribute to the synovitis progression of rheumatoid arthritis. | Exp Cell Res | 2024 | 39245197 | PubTator, text mining | PubMed |
| ALKBH5-mediated m6A demethylation ameliorates extracellular matrix deposition in cutaneous pathological fibrosis. | Clin Transl Med | 2024 | 39233335 | PubTator, text mining | PubMed |
| CRISPR-Cas13: Pioneering RNA Editing for Nucleic Acid Therapeutics. | Biodes Res | 2024 | 39228750 | PubTator, text mining | PubMed |
| The role of RNA m6A demethylase ALKBH5 in the mechanisms of fibrosis. | Front Cell Dev Biol | 2024 | 39220683 | PubTator, text mining | PubMed |
| Identification and Prognostic Value of m6A-Related Genes in Glioblastoma. | Neurol India | 2024 | 39216042 | PubTator, text mining | PubMed |
| The RNA Demethylases ALKBH5 and FTO Regulate the Translation of ATF4 mRNA in Sorafenib-Treated Hepatocarcinoma Cells. | Biomolecules | 2024 | 39199320 | PubTator, text mining | PubMed |
| Insights into the m6A demethylases FTO and ALKBH5 : structural, biological function, and inhibitor development. | Cell Biosci | 2024 | 39192357 | PubTator, text mining | PubMed |
| Complicated role of ALKBH5 in gastrointestinal cancer: an updated review. | Cancer Cell Int | 2024 | 39182071 | PubTator, text mining | PubMed |
| ALKBH5 governs human endoderm fate by regulating the DKK1/4-mediated Wnt/β-catenin activation. | Nucleic Acids Res | 2024 | 39166492 | PubTator, text mining | PubMed |
| The role of the ALKBH5 RNA demethylase in invasive breast cancer. | Discov Oncol | 2024 | 39127986 | PubTator, text mining | PubMed |
| ALKBH5-mediated N6-methyladenosine modification of HO-1 mRNA regulates ferroptosis in cobalt-induced neurodegenerative damage. | Environ Int | 2024 | 39047545 | PubTator, text mining | PubMed |
| LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53-driven tumour progression through miR-5683/FGF2. | Clin Transl Med | 2024 | 39039912 | PubTator, text mining | PubMed |
| Epitranscriptomic mechanisms of androgen signalling and prostate cancer. | Neoplasia | 2024 | 39033689 | PubTator, text mining | PubMed |
| The methyltransferase METTL3 regulates endothelial cell proliferation and inflammation via m6A RNA methylation-mediated TRAF1 expression. | Biochem Biophys Res Commun | 2024 | 39033551 | PubTator, text mining | PubMed |
| Identification of differential m6A RNA methylomes and ALKBH5 as a potential prevention target in the developmental neurotoxicity induced by multiple sevoflurane exposures. | FASEB J | 2024 | 39003634 | PubTator, text mining | PubMed |
N6-methyladenosine demethylase ALKBH5 homologous protein protects against cerebral I/R injury though suppressing SNHG3-mediated neural PANoptosis: Involvement of m6A-related macromolecules in the diseases of nervous system. | Int J Biol Macromol | 2024 | 38996894 | PubTator, text mining | PubMed |
| Branch Chain Amino Acid Metabolism Promotes Brain Metastasis of NSCLC through EMT Occurrence by Regulating ALKBH5 activity. | Int J Biol Sci | 2024 | 38993559 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=23